This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 year on year: consolidated revenue Rs 3,563 cr, net profit Rs 499 cr, both up; dividend Rs 3.50
DABUR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the quarter ended September 30, 2026, consolidated revenue was Rs 3,563.07 crore versus Rs 3,191.32 crore a year earlier; profit after tax was Rs 498.57 crore versus Rs 444.79 crore. Standalone Q2: revenue Rs 2,432.87 crore versus Rs 2,234.77 crore; profit after tax Rs 387.84 crore versus Rs 348.68 crore. Interim dividend: Rs 3.50 per share, Rs 620.88 crore. Prior figures were regrouped or reclassified. Auditors found no material issue in the limited review.
Growth and the dividend should support the stock, while a clean review reassures investors; slightly lower margins may limit gains.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹3,563 Cr | ₹3,191 Cr | +11.6% |
| Operating profit | ₹473.9 Cr | ₹433.0 Cr | +9.5% |
| Profit after tax | ₹498.6 Cr | ₹444.8 Cr | +12.1% |
| EBITDA margin | 17.8% | 18.4% | −0.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.